Very Rare Cancer Consortium Disease Spotlight & Research Roundtable

February 3, 2022, 5:00pm – 6:30pm | New York Genome Center

Please join us for the Very Rare Cancer Consortium Tumor Board Meeting. This new initiative aims to bring cancer researchers across New York to the table to discuss compelling rare cancer cases presented by physicians and scientists from the New York Genome Center’s partner institutions. Click here to learn more about the Very Rare Cancer Consortium.

Thursday, February 3, 2022
5pm – 6:30pm


Disease Spotlight & Research Roundtable

This will be a VIRTUAL meeting via Zoom.
Please note registration is required.

Ampullary and duodenal cancers are rare malignancies of the gastrointestinal tract, for which current treatment paradigms remain borrowed from nearby and/or related malignancies of the pancreas and colon, respectively. Clinical outcomes from ampullary and duodenal cancers, however, are distinct, reflecting genomic drivers that are unique to these cancer types. Survival from these malignancies are quite poor, highlighting the need for preclinical model development and translational studies that define specific molecular vulnerabilities to nominate effective clinical interventions.

During this VRCC Roundtable, we will hear from a panel of experts to articulate our current understanding of these rare tumor types, recent advances in clinical treatment and genomic characterization, and collaborative opportunities to advance the field further.



Rohit Chandwani, MD, PhD
Assistant Professor of Medicine
Division of Liver Transplantation, Hepatobiliary & Pancreatic Surgery
Department of Surgery
Department of Cell and Developmental Biology
Sandra and Edward Meyer Cancer Center
Weill Cornell Medicine


Brett Ecker, MD
Clinical Fellow
Memorial Sloan Kettering Cancer Center


Arvind Rishi, MD, FCAP
Associate Professor, Donald Barbara Zucker School of Medicine at Hofstra/Northwell Health
Gastrointestinal and Hepatobiliary Pathologist
Medical Director, Northwell Health Biospecimen Repository (NHBR)
Northwell Health Laboratories



Any questions on this event, contact